AI assistant
Sending…
Vitrolife — Major Shareholding Notification 2016
Feb 4, 2016
2989_iss_2016-02-04_2ea652b0-0f72-4be2-96c4-5da328cefcd7.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Vitrolife AB
Holder
Nordea Funds Oy
Instrument
| Instrument | Ordinary Shares SE0000816043 | |
|---|---|---|
| Before the transaction | ||
| Shares | 1,154,422 | |
| Voting rights | 1,154,422 | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 03/02/2016 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 1,048,034 | |
| Directly held voting rights | 1,048,034 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 4.8274 % | |
| Directly held voting rights | 4.8274 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 4.8274 % | 1,048,034 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 4.8274 % | 1,048,034 |
| Group total holdings | ||
| Voting rights 1,048,034 Percentage of voting rights 4.8274 |
||
| Published | ||
| 04/02/2016 10:39 | ||
| Contact Name Maiken Lesemann |
||
| Phone 004555472020 |
Email [email protected] | |
| CLOSE |
||
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Vitrolife
Board/Management Information
2026
May 22
Board/Management Information
2026
May 22
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 1
Proxy Solicitation & Information Statement
2026
Apr 1
Board/Management Information
2026
Apr 1
Board/Management Information
2026
Apr 1
Annual Report
2026
Mar 26
Annual Report
2026
Mar 26